Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
PaperCitations, authors & open-access status
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2022 year and gold oa status.
11
Citations
2022
Year
gold
OA Status